How can we make cancer-focused clinical trials more inclusive while also raising the quality of overall research? That sounds like a win-win value proposition. But…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.